Table 1.
Patients’ clinicopathological and laboratory characteristics.
| Characteristics | No. (%) |
|---|---|
| Median age (at the time of diagnosis) | 62 (range, 23-86 years) |
| Gender (male-to-female ratio) | 1.9:1.0 |
| Male | 27 (65.9) |
| Female | 14 (34.1) |
| Presenting symptoms | |
| Abdominal pain or discomfort | 22 (53.7) |
| Fatigue | 9 (22.0) |
| Jaundice | 6 (14.6) |
| Anorexia | 6 (14.6) |
| Nausea and/or vomiting | 7 (17.1) |
| B symptoms | |
| Fever | 8 (19.5) |
| Weight loss | 7 (17.1) |
| Night sweats | 4 (9.8) |
| Hepatomegaly | 7 (17.1) |
| Splenomegaly | 4 (9.8) |
| Pre-existing liver disease | |
| Chronic hepatitis | 6 (14.6) |
| Cirrhosis | 4 (9.8) |
| Liver transplantation | 4 (9.8) |
| Polycystic liver disease | 1 (2.4) |
| Radiological presentation | |
| Multiple lesions | 22 (53.7) |
| Solitary lesion | 15 (36.6) |
| Diffuse infiltration | 3 (7.3) |
| Histopathological diagnosis | |
| Diffuse large B-cell lymphoma | 27 (65.9) |
| Marginal zone B-cell lymphoma | 4 (9.8) |
| Follicular lymphoma grade 1 | 3 (7.3) |
| Precursor cell lymphoblastic lymphoma | 2 (4.9) |
| Mature T-cell lymphoma | 2 (4.9) |
| Small lymphocytic type T-cell lymphoma | 1 (2.4) |
| Malignant lymphoma small lymphocytic | 1 (2.4) |
| Burkitt lymphoma | 1 (2.4) |
| Treatment | |
| Combination chemotherapy | 30 (73.2) |
| Radiotherapy/chemo-radiotherapy | 4 (9.8) |
| Surgery | 4 (9.8) |